Synaffix B.V., a Lonza company (SIX:LONN) focused on commercializing its clinical-stage bioconjugation platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class ...
As the U.S. stock market experiences a mixed performance with major indices like the Dow Jones and Nasdaq reaching new highs, investors continue to explore diverse opportunities across various sectors ...